Open AccessA superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones
Author(s) -
Shimada Yoshitaka,
Adachi Mizuho,
Kobayashi Noritada,
Okada Takemichi,
Yamazaki Hitoshi,
Nagaba Yasushi,
Yokomori Hiroaki
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1417
Subject(s) - medicine , anasarca , organomegaly , hormone , corticosteroid , myelofibrosis , immunology , polyneuropathy , bone marrow
Key Clinical Message Peripheral lymphocyte subsets may be less time‐consuming and are a prognostic tool for managing thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly ( TAFRO ) syndrome. Here, we report a superelderly case of plasma cell type TAFRO syndrome treated effectively using corticosteroid hormones.